Supplementary Data File for "A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis"

Dataset

DOI PID

Supplementary Materials for the Paper "A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis" that is published in the Journal of the American Academy of Dermatology (JAAD).

THIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF FILES AND ACCESS THE FILES IN THIS DATASET CLICK ON THE DOI-LINK ABOVE

Identifier
DOI	https://doi.org/10.17632/bh6p4rk5j9.1
PID	https://nbn-resolving.org/urn:nbn:nl:ui:13-5i-coai
Metadata Access	https://easy.dans.knaw.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=oai:easy.dans.knaw.nl:easy-dataset:340247

Provenance
Creator	Rho, Y
Publisher	Data Archiving and Networked Services (DANS)
Contributor	Young Hee Rho
Publication Year	2024
Rights	info:eu-repo/semantics/openAccess; License: http://creativecommons.org/licenses/by/4.0; http://creativecommons.org/licenses/by/4.0
OpenAccess	true

Representation
Resource Type	Dataset
Discipline	Other

Supplementary Data File for &quot;A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis&quot;

Supplementary Data File for "A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis"